The adjacent vessel sign on breast MRI: New data and a subgroup analysis for 1,084 histologically verified cases

Korean Journal of Radiology

Volumn 11, Issue 2, 2010, Pages 178-186

  Dietzel, Matthias ^a   Baltzer, Pascal A T ^a   Vag, Tibor ^a   Herzog, Aimee ^a   Gajda, Mieczyslaw ^a   Camara, Oumar ^a   Kaiser, Werner A ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Breast; Contrast Media; Descriptor; Histology; MR; Neoangiogenesis; Sign

Indexed keywords

ADVANCED CANCER; ARTICLE; BLOOD VESSEL; BREAST CARCINOMA; BREAST LESION; BREAST TUMOR; CANCER GRADING; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PREVALENCE; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASMS, DUCTAL, LOBULAR, AND MEDULLARY; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 77950641135     PISSN: 12296929     EISSN: None     Source Type: Journal    
DOI: 10.3348/kjr.2010.11.2.178     Document Type: Article

References (35)

1. Fischer DR, Malich A, Wurdinger S, Boettcher J, Dietzel M, Kaiser WA. The adjacent vessel on dynamic contrast-enhanced breast MRI. AJR Am J Roentgenol 2006; 187:W147-W151
2. Fischer DR, Wurdinger S, Boettcher J, Malich A, Kaiser WA. Further signs in the evaluation of magnetic resonance mammography: a retrospective study. Invest Radiol 2005;40:430-435
3. Malich A, Fischer DR, Wurdinger S, Boettcher J, Marx C, Facius M, et al. Potential MRI interpretation model: differentiation of benign from malignant breast masses. AJR Am J Roentgenol 2005;185:964-970
4. Peters NH, Borel Rinkes IH, Zuithoff NP, Mali WP, Moons KG, Peeters PH. Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology 2008;246:116-124
5. Lee SH, Cho N, Kim SJ, Cha JH, Cho KS, Ko ES, et al. Correlation between high resolution dynamic MR features and prognostic factors in breast cancer. Korean J Radiol 2008;9:10-18
6. Ko EY, Han BK, Shin JH, Kang SS. Breast MRI for evaluating patients with metastatic axillary lymph node and initially negative mammography and sonography. Korean J Radiol 2007;8:382-389
7. Kim do Y, Moon WK, Cho N, Ko ES, Yang SK, Park JS, et al. MRI of the breast for the detection and assessment of the size of ductal carcinoma in situ. Korean J Radiol 2007;8:32-39
8. Renz DM, Baltzer PA, Kullnig PE, Bottcher J, Vag T, Gajda M, et al. Clinical value of computer-assisted analysis in MR mammography. A comparison between two systems and three observers with different levels of experience. Rofo 2008;180:968-976
9. Williams TC, DeMartini WB, Partridge SC, Peacock S, Lehman CD. Breast MR imaging: computer-aided evaluation program for discriminating benign from malignant lesions. Radiology 2007;244:94-103
10. Thomas MA, Lipnick S, Velan SS, Liu X, Banakar S, Binesh N, et al. Investigation of breast cancer using two-dimensional MRS. NMR Biomed 2009;22:77-91
11. Mountford C, Ramadan S, Stanwell P, Malycha P. Proton MRS of the breast in the clinical setting. NMR Biomed 2009;22:54-64
12. Sardanelli F, Fausto A, Esseridou A, Di Leo G, Kirchin MA. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance. Invest Radiol 2008;43:236-242
13. Yabuuchi H, Matsuo Y, Okafuji T, Kamitani T, Soeda H, Setoguchi T, et al. Enhanced mass on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images. J Magn Reson Imaging 2008;28:1157-1165
14. Park JM, Park JH. Human in-vivo 31P MR spectroscopy of benign and malignant breast tumors. Korean J Radiol 2001;2:80-86
15. Vassiou K, Kanavou T, Vlychou M, Poultsidi A, Athanasiou E, Arvanitis DL, et al. Characterization of breast lesions with CE-MR multimodal morphological and kinetic analysis: comparison with conventional mammography and high-resolution ultrasound. Eur J Radiol 2009;70:69-76
16. Tardivon AA, Athanasiou A, Thibault F, El Khoury C. Breast imaging and reporting data system (BIRADS): magnetic resonance imaging. Eur J Radiol 2007;61:212-215
17. Dietzel M, Baltzer PAT, Vag T, Gajda M, Camara O, Kaiser WA. The hook sign for differential diagnosis of malignant from benign lesions in magnetic resonance mammography -Experience in a study of 1084 histologically verified cases. Acta Radiol 2010;51:137-143
18. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19:403-410
19. Armitage P, Berry G. Statistical methods in medical research, 3rd ed. London: Blackwell Scientific, 1994:131
20. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998;17:857-872
21. Bland M. An introduction to medical statistics. Oxford: Oxford University Press, 2000
22. Langer SA, Horst KC, Ikeda DM, Daniel BL, Kong CS, Dirbas FM. Pathologic correlates of false positive breast magnetic resonance imaging findings: which lesions warrant biopsy? Am J Surg 2005;190:633-640
23. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8
24. Bässler R. Mamma. In: Remmele W, ed. Pathologie. Berlin: Springer, 1997:135-365
25. Fridman V, Humblet C, Bonjean K, Boniver J. Assessment of tumor angiogenesis in invasive breast carcinomas: absence of correlation with prognosis and pathological factors. Virchows Arch 2000;437:611-617
26. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-1887
27. Westerhof JP, Fischer U, Moritz JD, Oestmann JW. MR imaging of mammographically detected clustered microcalcifications: is there any value? Radiology 1998;207:675-681
28. Gilles R, Meunier M, Lucidarme O, Zafrani B, Guinebretiere JM, Tardivon AA, et al. Clustered breast microcalcifications: evaluation by dynamic contrast-enhanced subtraction MRI. J Comput Assist Tomogr 1996;20:9-14
29. Brinck U, Fischer U, Korabiowska M, Jutrowski M, Schauer A, Grabbe E. The variability of fibroadenoma in contrast-enhanced dynamic MR mammography. AJR Am J Roentgenol 1997;168:1331-1334
30. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992;267:10931-10934
31. Kaiser WA. MR mammography--a critical stocktaking. Rofo 1996;165:425-427
32. Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 1999;213:881-888
33. Nunes LW, Schnall MD, Orel SG, Hochman MG, Langlotz CP, Reynolds CA, et al. Breast MR imaging: interpretation model. Radiology 1997;202:833-841
34. Kuhl CK. Current status of breast MR imaging. Part 2. Clinical applications. Radiology 2007;244:672-691
35. Liberman L, Mason G, Morris EA, Dershaw DD. Does size matter? Positive predictive value of MRI-detected breast lesions as a function of lesion size. AJR Am J Roentgenol 2006;186:426-430